The Impact of Psychological Stress on Sarcoidosis Activity and Development: The Role of the HPA Axis, Neuroendocrine Mechanisms and the Immune Response
Abstract
Sarcoidosis is a chronic inflammatory disease of unknown cause. However, evidence suggests that psychological stress may be an important factor not only in worsening symptoms but also in the development of the disease itself. Long-term activation of the hypothalamic–pituitary–adrenal (HPA) axis associated with chronic stress may lead to immune dysregulation, cortisol resistance and chronic inflammation, which could trigger or accelerate granuloma formation. This paper analyses how sustained high stress may contribute to the development of sarcoidosis through neuroendocrine and immune mechanisms.
---
1. Introduction
Sarcoidosis is a multisystem granulomatous disease in which the immune system is activated in a way that resembles autoimmune disease, although no definite external cause is known. Although environmental factors such as infections and antigen exposure have traditionally been considered the main triggers, increasing evidence suggests that chronic stress may play a role in initiating sarcoidosis.
Stress triggers complex neuroendocrine and immune responses, including:
Activation of the HPA axis, leading to changes in cortisol and ACTH levels
Dysregulation of the sympathetic nervous system, increasing the production of adrenaline and noradrenaline
Increased levels of pro-inflammatory cytokines, which may cause inflammation and a granulomatous response
Disruption of the balance between Th1 and Th2 immune responses, which may promote excessive macrophage activation and granuloma formation
This paper examines whether sustained stress may play a role in the development of sarcoidosis and how it may worsen symptoms in patients who already have the disease.
---
2. The relationship between chronic stress and the development of sarcoidosis
2.1. Epidemiological evidence
Research suggests that people exposed to high levels of psychological stress have an increased risk of developing diseases associated with immune dysregulation, including autoimmune diseases and inflammatory disorders.
Retrospective studies have shown that patients with sarcoidosis often experienced major stressful events—such as the death of a close person, financial difficulties or chronic stress at work—before the first symptoms appeared.
Clinical studies indicate an association between increased cortisol levels and a reduced response to anti-inflammatory mechanisms in patients with active sarcoidosis.
A higher incidence of sarcoidosis has been observed among war veterans, suggesting that traumatic stress may contribute to the development of the disease.
2.2. The HPA axis and its role in the development of sarcoidosis
The HPA axis controls the body’s response to stress through the release of cortisol. Under normal conditions, cortisol has anti-inflammatory effects. During chronic stress, however, cortisol resistance may develop, meaning that the immune system becomes less sensitive to its effects.
In patients with sarcoidosis, there may be:
Higher cortisol levels but reduced effectiveness in suppressing inflammation
Increased production of pro-inflammatory cytokines (TNF-alpha, IL-6 and IFN-gamma), which are important in granuloma formation
Increased macrophage activity, with granulomas forming in response to persistent inflammation
This imbalance may lead to an uncontrolled inflammatory response and the initiation of sarcoidosis in predisposed individuals.
---
3. Neuroendocrine and immune mechanisms linking stress and sarcoidosis
3.1. The effect of stress on the immune response
Psychological stress may shift the immune system towards a Th1-dominant response, which is important in the development of sarcoidosis.
Th1 cytokines (IFN-gamma and IL-12) promote the activation of macrophages, which are responsible for granuloma formation.
Cortisol normally inhibits the Th1 response, but chronic stress may reduce its effectiveness.
Hyperactivation of macrophages may lead to chronic inflammation even when no clearly identifiable pathogen is present.
3.2. Autonomic nervous system dysfunction
Chronic stress also activates the sympathetic nervous system, which may modulate the immune response in a way that favours the development of sarcoidosis.
Increased adrenaline and noradrenaline levels may increase the expression of inflammatory molecules such as ICAM-1, which recruit immune cells into lung tissue.
Reduced activity of the vagus nerve, which normally has anti-inflammatory effects, may contribute to uncontrolled inflammation.
Bronchoconstriction and increased blood-vessel permeability may stimulate local immune activation and facilitate granuloma formation.
These mechanisms show how chronic stress may not only worsen existing disease but also participate in the initiation of sarcoidosis in predisposed people.
---
4. Conclusion
Evidence shows that chronic stress can influence sarcoidosis activity through dysregulation of the HPA axis, cortisol resistance and increased production of pro-inflammatory cytokines. There is also increasing evidence that prolonged high stress may play a role in the development of sarcoidosis itself.
Dysfunction of neuroendocrine and immune mechanisms in people under stress may lead to:
1. Increased macrophage activation and granuloma formation
2. Increased expression of inflammatory cytokines, promoting disease progression
3. Reduced ability of cortisol to regulate inflammation, increasing the risk of developing sarcoidosis
These findings suggest that stress management could be an important factor not only in treatment but also in preventing sarcoidosis in people at risk. Further research is needed to clarify the precise role of stress in the pathogenesis of sarcoidosis and to develop strategies for reducing its impact on the disease.
